News
-
![]()
Press Releases
-
![Informative content aimed at educating the public about lung cancer, early detection methods, the importance of biomarkers, and general health tips related to cancer prevention and care.]()
Educational Articles
-
![Detailed scientific studies and findings related to lung cancer detection, biomarker research, and other relevant medical research conducted or published by Cizzle Bio or related entities.]()
Research Papers
Cizzle Bio News
Stay informed with the latest updates on Cizzle Bio's milestones, industry news, and significant events. Here, you will find:
-
![Business professionals reviewing company milestones and progress reports in lung cancer diagnostics, highlighting key achievements in medical innovation.]()
Company Milestones
Discover our key achievements and progress in developing cutting-edge lung cancer diagnostics.
-
![Digital collage of news screens showcasing the latest trends and advancements in the biotechnology field, highlighting industry news and updates.]()
Industry News
Keep up with the latest trends and advancements in the biotechnology field.
-
![Doctor and business professional shaking hands, symbolizing strategic partnerships and collaborations to enhance cancer detection efforts.]()
Collaborations and Partnerships
Learn about our strategic partnerships and collaborative efforts to enhance cancer detection.
-
![Doctor presenting at a conference, discussing significant events and advancements in healthcare and biotechnology, highlighting Cizzle Bio's impact.]()
Significant Events
Get insights into important events and conferences that highlight our impact on healthcare and biotechnology.
Latest
Revolutionizing Gastric Cancer Detection: Introducing Cizzle Bio’s New Blood Test
Cizzle Bio’s new DEX-G2 test offers a non-invasive, highly accurate solution for early gastric cancer detection. Designed to empower patients and clinicians, DEX-G2 is the latest innovation in our mission to detect cancer early and save lives.
Cizzle Bio, Inc. is expanding its innovative CIZ1B Biomarker Test for early lung cancer detection to the Caribbean, bringing life-saving diagnostics to over 45 million people.